Local Hospital Participates In COVID-19 Treatment Clinical Trial
In Meridian, Anderson Regional Health System is now participating in a clinical trial for treatment of COVID-19.
The clinical trial is being led by the Mayo Clinic. In this trial researchers are testing the use of donated blood as a treatment for people that are severely ill with COVID-19.
Seeking convalescent plasma donated from patients that have recovered from COVID-19, they hope to treat the severely ill patients with the antibodies to the disease from the recovered patient’s blood, and boost their ability to fight the virus.
Anderson’s Laboratory Director, Marilyn Bell, shares how those who have recovered from the coronavirus can help with this clinical trial.
“They need to have a prior diagnosis of COVID-19 documented by a laboratory test. Also, they
need to be symptom free for 28 days prior to their donations. if there is a female involved, they either have to have no history of pregnancy or they test negative for HLA antibodies”, said Marilyn Bell, Anderson’s Laboratory director.
Director Bell tells Twin States, that Anderson Regional Health System plans to participate in the clinical trial as long as they are needed.
“Its difficult to tell how well its doing at this point in time, but they observed a lot of encouraging observations in the short amount of time that we’ve been involved with the clinical trials and we anticipate participating with the trials as long as we’re needed and as long as Mayo requires it. Our hope, that we --with enough interest in participating, to get Mississippi Blood Services to bring their mobile unit here for those particular donors, so that it won’t be so cumbersome for them to go to Flowood for testing there”, said Bell.
For more information on how you can donate, contact Anderson’s Laboratory Director Marilyn Bell at 601-553-6868 Monday – Friday 7:00am-3:30pm.